PhysiologybioRxivPreprint
Cardiac gene therapy with PDE2A limits remodeling and arrhythmias in mouse models of heart failure induced by catecholamines
DOI 10.1101/2023.04.17.537274
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
3 papers
Recent·Most cited
M. Mazevet, A. Belhadef, M. Ribeiro…·E. Morel
This study shows that inhibiting EPAC1 protects the heart from doxorubicin-induced toxicity without affecting its cancer-killing effects.
M. BARTHE, F. LEFEBVRE, E. LANGLOIS…·R. FISCHMEISTER
This paper investigates the functional differences between cardiac β-adrenergic receptors in T-tubules and outer surface membrane using a PEGylation strategy to selectively activate surface receptors.